A newly developed miniaturized heart-lung machine-expression of inflammation in a small animal model

Artificial Organs

Volumn 34, Issue 11, 2010, Pages 911-917

  Schnoering, Heike ^a   Arens, Jutta ^b   Terrada, Estella ^a   Sachweh, Joerg S ^a   Runge, Maximilian ^a   Schmitz Rode, Thomas ^b   Steinseifer, Ulrich ^b   Vazquez Jimenez, Jaime F ^a  

^a Medical Faculty   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Animal model; Cardiopulmonary bypass; Heart lung machine; Inflammation; Pediatrics

Indexed keywords

ARTIFICIAL HEART; BIOLOGICAL ORGANS; BLOOD; BLOOD VESSELS; GASES; HEART; PATHOLOGY;

ANIMAL MODEL; CANNULATIONS; CARDIOPULMONARY BYPASS; IL-1Β; INFLAMMATORY REACTION; MACHINE DYNAMICS; MULTIORGAN FAILURE; ROLLER PUMPS; SMALL ANIMAL MODEL; TNF Α;

ANIMALS;

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CLAMPING; ARTICLE; BLOOD GAS ANALYSIS; CANNULATION; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; EXTRACORPOREAL CIRCULATION; FEMALE; HEART LUNG MACHINE; HEMODYNAMIC PARAMETERS; MINIATURE HEART LUNG MACHINE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SKIN INCISION; STERNOTOMY; WEANING;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 78649560751     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2010.01146.x     Document Type: Article

References (23)

1. Lau CL, Posther KE, Stephenson GR, et al. Mini-circuit cardiopulmonary bypass with vacuum assisted venous drainage: feasibility of an asanguineous prime in the neonate. Perfusion 1999;14:389-96.
2. Edmunds LH. Advances in the heart-lung machine after John and Mary Gibbon. Ann Thorac Surg 2003;76:S2220-S2223.
3. Schnoering H, Arens J, Sachweh JS, et al. The Aachen miniaturized heart-lung machine-first results in a small animal model. Artif Organs 2009;33:935-40.
4. Gibbon JH. The development of the heart-lung apparatus. Am J Surg 1978;135:608-19.
5. Miyaji K, Miyamoto T, Kohira S, et al. Miniaturized cardiopulmonary bypass system in neonates and small infants. Interact Cardiovasc Thorac Surg 2008;7:75-8.
6. Kotani Y, Honjo O, Nakakura M, et al. Impact of miniaturization of cardiopulmonary bypass circuit on blood transfusion requirement in neonatal open-heart surgery. ASAIO J 2007;53:662-5.
7. Ando M, Takahashi Y, Suzuki N. Open heart surgery for small children without homologous blood transfusion by using remote pump head system. Ann Thorac Surg 2004;78:1717-22.
8. Vohra HA, Whistance R, Modi A, Ohri SK. The inflammatory response to miniaturised extracorporeal circulation: a review of the literature. Mediators Inflamm 2009;2009:707042.
9. Kozik DJ, Tweddell JS. Characterizing the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg 2006;81:S2347-S2354.
10. Qing M, Schumacher K, Heise R, et al. Intramyocardial synthesis of pro- and anti-inflammatory cytokines in infants with congenital cardiac defects. J Am Coll Cardiol 2003;41:2266-74.
11. Seghaye MC, Grabitz RG, Duchateau J, et al. Inflammatory reaction and capillary leak syndrome related to cardiopulmonary bypass in neonates undergoing cardiac operations. J Thorac Cardiovasc Surg 1996;112:687-97.
12. Hövels-Gürich HH, Schumacher K, Vazquez-Jimenez JF, et al. Cytokine balance in infants undergoing cardiac operation. Ann Thorac Surg 2002;73:601-8. discussion 608-9.
13. Seghaye MC, Duchateau J, Grabitz RG, et al. Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure. J Thorac Cardiovasc Surg 1993;106:978-87.
14. Hall TS. The pathophysiology of cardiopulmonary bypass. The risks and benefits of hemodilution. Chest 1995;107:1125-33.
15. Holzheimer RG, Molloy RG, Görlach H, Wilkert S, Hehrlein F. IL-6 and TNF alpha release in association with neutrophil activation after cardiopulmonary bypass surgery. Infection 1994;22:37-42.
16. Arens J, Schnöring H, Reisch F, Vázquez-Jiménez JF, Schmitz-Rode T, Steinseifer U. Development of a miniaturized heart-lung machine for neonates with congenital heart defect. ASAIO J 2008;54:509-13.
17. Zimmermann AK, Simon P, Seeburger J, et al. Cytokine gene expression in monocytes of patients undergoing cardiopulmonary bypass surgery evaluated by real-time PCR. J Cell Mol Med 2003;7:146-56.
18. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 2002;21:232-44.
19. Mabika M, Laburn H. The role of tumour necrosis factor-alpha (TNF-alpha) in fever and the acute phase reaction in rabbits. Pflugers Arch 1999;438:218-23.
20. Yeh C-H, Chen T-P, Lee C-H, Wu Y-C, Lin Y-M, Lin PJ. Cardioplegia-induced cardiac arrest under cardiopulmonary bypass decreased nitric oxide production which induced cardiomyocytic apoptosis via nuclear factor kappa b activation. Shock 2007;27:422-8.
21. Yeh C-H, Lin Y-M, Wu Y-C, Lin PJ. Inhibition of nf-kappa b activation can attenuate ischemia/reperfusion-induced contractility impairment via decreasing cardiomyocytic proinflammatory gene up-regulation and matrix metalloproteinase expression. J Cardiovasc Pharmacol 2005;45:301-9.
22. Zagariya A, Bhat R, Navale S, Vidyasagar D. Cytokine expression in meconium-induced lungs. Indian J Pediatr 2004;71:195-201.
23. Skrzypchak AM, Miskulin J, Bartlett RH, Annich GM. Developing a small animal model of extracorporeal circulation. ASAIO J 2006;52:296-302.